These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 2279046

  • 1. Surfactant replacement in spontaneously breathing babies with hyaline membrane disease--a pilot study.
    Victorin LH, Deverajan LV, Curstedt T, Robertson B.
    Biol Neonate; 1990; 58(3):121-6. PubMed ID: 2279046
    [Abstract] [Full Text] [Related]

  • 2. [Treatment of hyaline membrane disease in the preterm newborn with exogenous lung surfactant: a controlled study].
    Sánchez-Mendiola M, Martínez-Natera OC, Herrera-Maldonado N, Ortega-Arroyo J.
    Gac Med Mex; 2005; 141(4):267-71. PubMed ID: 16164120
    [Abstract] [Full Text] [Related]

  • 3. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW.
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
    Jin HZ, Chen C, Jin QL, Shao XM.
    Chin Med J (Engl); 1989 Dec; 102(12):944-6. PubMed ID: 2517741
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Surfactant treatment in experimental hyaline membrane disease.
    Nilsson R, Grossmann G, Berggren P, Robertson B.
    Eur J Respir Dis; 1981 Dec; 62(6):441-9. PubMed ID: 6922790
    [Abstract] [Full Text] [Related]

  • 9. The late administration of surfactant.
    Ballot DE, Rothberg AD, Davies VA.
    S Afr Med J; 1995 Jul; 85(7):644-6. PubMed ID: 7482080
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of exogenous surfactant therapy on dynamic compliance during mechanical breathing in preterm infants with hyaline membrane disease.
    Couser RJ, Ferrara TB, Ebert J, Hoekstra RE, Fangman JJ.
    J Pediatr; 1990 Jan; 116(1):119-24. PubMed ID: 2404097
    [Abstract] [Full Text] [Related]

  • 13. Surfactant treatment may accelerate epithelial cell regeneration in hyaline membrane disease of the newborn.
    Gonda TA, Hutchins GM.
    Am J Perinatol; 1998 Jan; 15(9):539-44. PubMed ID: 9890252
    [Abstract] [Full Text] [Related]

  • 14. Review of experimental hyaline membrane disease.
    Robertson B.
    Diagn Histopathol; 1981 Jan; 4(1):49-60. PubMed ID: 7018865
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hyaline membrane disease treated with bovine surfactant.
    Smyth JA, Metcalfe IL, Duffty P, Possmayer F, Bryan MH, Enhorning G.
    Pediatrics; 1983 Jun; 71(6):913-7. PubMed ID: 6687937
    [Abstract] [Full Text] [Related]

  • 20. Pulmonary surfactant replacement in respiratory distress syndrome.
    Vidyasagar D, Shimada S.
    Clin Perinatol; 1987 Dec; 14(4):991-1015. PubMed ID: 3322633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.